Our Mission
The SSADH Association is a voluntary, not-for-profit, 501(c) (3) organization dedicated to helping children and families affected by an ultra-rare neurometabolic disorder known as Succinic Semialdehyde Dehydrogenase Deficiency or SSADH.
The SSADH Association is committed to those affected with this neurotransmitter disease through education, advocacy and research.
News & Updates
Proceedings Published from Virtual Conference
The manuscripts from the 2020 Virtual SSADH Conference are being published on-line through the Journal of Child Neurology. We are…
Read More
Inducible SSADH Mouse Model
In early 2020, Drs. Rotenberg and Lee from Boston Children’s Hospital were given a one year $100,000 grant to create…
Read More
SSADH Consortium (SDIC)
The SSADH Virtual Conference was held on July 9 and 10, 2020. The top SSADH researchers and clinicians from around…
Read More
Successful 22nd Annual Chip for Charity
The 22nd Annual Chip for Charity Golf Outing was help on September 10 in southern Wisconsin in honor of Sam…
Read MoreThe 2020 Virtual SSADH Conference held July 9 and 10, was made up of two half day events including formal presentations by outstanding clinicians and researchers in the field from around the world, allowing for a question and answer session at the end of each speaker.
The goal of the conference was to share updates from the on-going Natural History Study, encourage brainstorming between researchers and clinicians and discuss the best directions for future research moving forward. A portion of the agenda was devoted to update families and caregivers of SSADH patients.
The proceeding from this event will be published in the Journal of Child Neurology at a later date.
Below are the links to the recording for each session. The recordings will be available until August 1st, 2020.
2020 SSADH Conference - Session 1
2020 SSADH Conference - Session 2
2020 SSADH Conference - Session 3
2020 SSADH Conference - Session 4
Conference Organizers: Dr. Jean-Baptiste Roullet, Dr. K. Michael Gibson
Dr. Phillip Pearl, Dr. Melissa DiBacco, Alice McConnell, & Carolyn Hoffman
